Head and Neck Squamous Cell Carcinoma Clinical Trials in Newark, Delaware

3 studies are recruiting for head and neck squamous cell carcinoma in Newark, Delaware right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

    This phase II trial studies how well radiation therapy with or without cisplatin works in treating patients with stage III-IVA squamous cell carcinoma of the head and neck who have undergone surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Drugs used in chem…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Delaware Clinical and Laboratory Physicians PA, Newark, Delaware
    Locations
    679 in total
    Run by
    ECOG-ACRIN Cancer Research Group

    See if you can join NCT02734537 on ClinicalTrials.gov

  2. Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

    This phase III trial compares cetuxumab to chemotherapy, carboplatin and paclitaxel, with intensity modulated radiation therapy for the treatment of patients with head and neck cancer who are unable to receive cisplatin. Cetuximab is in a class of medications called monoclonal antibodies. It binds …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Helen F Graham Cancer Center, Newark, Delaware
    Locations
    63 in total
    Run by
    NRG Oncology

    See if you can join NCT07441681 on ClinicalTrials.gov

  3. A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

    This is a Phase 3 randomized, open-label study to evaluate the efficacy and safety of petosemtamab plus pembrolizumab vs pembrolizumab in first-line treatment of recurrent or metastatic PD-L1+ head and neck squamous cell carcinoma.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Site 19, Newark, Delaware
    Locations
    205 in total
    Run by
    Merus B.V.

    See if you can join NCT06525220 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.